Karen Wagner (L) and Joël Jean-Mairet (Ysios)

Eight bets in, Spain's Ys­ios of­fi­cial­ly ties a bow around €216M fund

Hav­ing played a part in pi­o­neer­ing biotech ven­ture in­vest­ing in Spain, Ys­ios Bio­Fund has closed its third and largest fund to keep push­ing the en­ve­lope in Eu­rope — and al­so the US.

The €216 mil­lion ($264 mil­lion) fund ex­ceed­ed their ini­tial tar­get, said man­ag­ing part­ner Joël Jean-Mairet, thanks to en­thu­si­as­tic back­ers such as the Eu­ro­pean In­vest­ment Fund.

As much as 60% of the port­fo­lio of Ys­ios Bio­Fund III is al­ready in place, with eight in­vest­ments made over the past year out of the planned 15 — each of which could get up to €20 mil­lion de­pend­ing on the stage.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.